Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Assets Average (2017 - 2025)

Historic Assets Average for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $198.9 million.

  • Puma Biotechnology's Assets Average fell 656.41% to $198.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.9 million, marking a year-over-year decrease of 656.41%. This contributed to the annual value of $221.9 million for FY2024, which is 192.8% down from last year.
  • Latest data reveals that Puma Biotechnology reported Assets Average of $198.9 million as of Q3 2025, which was down 656.41% from $195.5 million recorded in Q2 2025.
  • Over the past 5 years, Puma Biotechnology's Assets Average peaked at $259.3 million during Q2 2021, and registered a low of $195.5 million during Q2 2025.
  • Moreover, its 5-year median value for Assets Average was $210.4 million (2022), whereas its average is $215.0 million.
  • In the last 5 years, Puma Biotechnology's Assets Average surged by 921.85% in 2021 and then tumbled by 2396.98% in 2022.
  • Quarter analysis of 5 years shows Puma Biotechnology's Assets Average stood at $226.4 million in 2021, then fell by 7.08% to $210.4 million in 2022, then increased by 3.16% to $217.1 million in 2023, then fell by 0.02% to $217.0 million in 2024, then decreased by 8.36% to $198.9 million in 2025.
  • Its Assets Average stands at $198.9 million for Q3 2025, versus $195.5 million for Q2 2025 and $204.8 million for Q1 2025.